相关实验视频

Updated: Jul 21, 2025

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Generation of Induced Neural Stem Cells from Peripheral Mononuclear Cells and Differentiation Toward Dopaminergic Neuron Precursors for Transplantation Studies

Published on: July 11, 2019

一种定义的方法,用于将人类iPSC区分为中脑多巴胺原体,可安全地恢复帕金森病中的运动缺陷

Ryota Nakamura¹, Risa Nonaka^1,2,3, Genko Oyama¹

¹Department of Neurology, Faculty of Medicine, Juntendo University, Tokyo, Japan.

Frontiers in neuroscience

|July 28, 2023

概括

这项研究开发了一种新方法,从人类诱导的多能干干细胞 (iPSCs) 中产生中脑多巴胺基 (mDA) 原生细胞,用于帕金森病 (PD) 治疗. 移植细胞在没有瘤形成的PD模型小鼠中改善了运动功能,显示出治疗前景.

科学领域:

干细胞生物学干细胞生物学
神经科学是一个神经科学.
再生医学是一种再生医学.

背景情况:

帕金森病 (PD) 是一种神经退行性疾病,其特征是中脑多巴胺基 (mDA) 神经元的损失.
目前使用诱导多能干细胞 (iPSC) 衍生的mDA神经原始细胞治疗PD的细胞疗法方法在动物模型中显示出治疗潜力,并且正在临床试验中.
提高分化协议的安全性和效率对于PD的大规模细胞疗法研究至关重要.

研究的目的:

评估一项先前报告的方法,用于使用三种抑制剂治疗诱导人类iPSCs的多巴胺基原生细胞.
在体外评估这些iPSC衍生的mDA原始细胞的分化效率和特性.
确定移植的mDA原始体的体内疗效,安全性和差异化能力在PD小鼠模型中.

主要方法:

人类iPSC被分化为mDA原生细胞使用CTraS介导的方法,涉及三种抑制剂.
在体外表征原生细胞标记物和多巴胺基基分化效率.
将诱导的mDA原始体移植到受6氧多巴胺损伤的PD模型小鼠中.
在体内评估运动功能,细胞存活率,分化和16周的瘤形成.

主要成果:

在分化协议中,mDA原生细胞的≥80%在体外主要分化为A9多巴胺基神经元.
在对PD模型小鼠进行移植后,超过90%的移植细胞分化为mDA神经元,约15%成熟为完全发育的mDA神经元.
在移植的小鼠中没有观察到瘤的形成.
在移植的PD模型小鼠中观察到运动功能的显著改善.

结论:

描述的分化协议为产生mDA原生细胞用于帕金森病细胞治疗提供了一个有前途的方法.
来自iPSC的mDA原始体在PD小鼠模型中表现出高效的体内差异化和功能恢复.
这种方法为推进帕金森病的基于细胞的疗法提供了潜在的战略.

关键词:

帕金森病是帕金森氏症的一种疾病.细胞移植移植细胞移植多巴胺类神经元的神经元 iPS 细胞细胞 iPS 细胞再生医学是一种再生医学.

更多相关视频

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Directed Dopaminergic Neuron Differentiation from Human Pluripotent Stem Cells

Published on: September 15, 2014

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Conversion of Human Induced Pluripotent Stem Cells iPSCs into Functional Spinal and Cranial Motor Neurons Using PiggyBac Vectors

Published on: May 1, 2019

相关概念视频

EPS and iPS Cells in Disease Research

EPS and iPS Cells in Disease Research

Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...

Induced Pluripotent Stem Cells

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...

iPS Cell Differentiation

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.